A Study to Determine if BHV-1400 is Effective and Safe in Adults With IgA Nephropathy

NCT07642050 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

420

Enrollment

INDUSTRY

Sponsor class

Conditions

IgA Nephropathy

Interventions

DRUG: BHV-1400
DRUG: Placebo

Sponsor

Biohaven Therapeutics Ltd.